A monthly headline price is a starting point for questions. It may refer to medicine alone, a particular presentation, an introductory offer, or a plan with separate service fees.
A useful estimate covers your actual prescription and a realistic period of care. Featured price records were refreshed October 5, 2026; the selected checkout and supply interval still need confirmation.
Compare the full recurring bill for the exact product, then ask what happens when the prescription or coverage changes.
Put the offers on the same billing period
CoreAge’s supplied annual tirzepatide quote is $129 per month, equivalent to $1,548 for twelve months; its public product page separately displays $149. Its full review explains the offer distinction and refund exceptions.
SuperHealthy displays $135 tirzepatide in the linked promotion and describes optional automatic refill. Likeness has $199 for one month or $1,548 for twelve, with other terms between them and automatic renewal. Those payment periods are different commitments.
Mochi lists a $79 one-month membership plus compounded tirzepatide from $90, dependent on dose. LillyDirect’s self-pay Zepbound starting figure is $299 for the starting strength, with presentation and supply-period conditions. Compare a named prescription and full care quote rather than treating every starting number as the same product.
Sources: CoreAge Rx: Tirzepatide product page · CoreAge Rx: Current promotional offer · SuperHealthy Rx: official glp offer · Likeness Rx — GLP-1 weight care · Mochi Health: Public care and pricing FAQs · LillyDirect: Zepbound self-pay options
Write down every part of the bill
Ask for the medicine price, visit or membership fee, any laboratory charge, shipping, supplies, and the billing interval. Confirm whether a quoted month means a specific number of doses and whether payment is required before the clinician determines eligibility.
For a subscription, note the renewal date and cancellation deadline. For a multi-month purchase, ask what happens if treatment changes or you cannot continue. A low average monthly figure can conceal a larger upfront commitment. Our provider shortlist organizes services by the questions their offers raise.
Sources: Mochi Health: Public care and pricing FAQs · Mochi Health: Terms · Mochi Health: Refunds · FDA: Managing medicine benefits and risks
Insurance is a separate calculation
An insurer may treat different products and diagnoses differently. Ask about the exact medicine, prior authorization, deductible, copayment, and renewal criteria. A provider offering authorization support cannot promise the insurer will approve a claim.
Do not assume a compounded prescription is covered because an approved brand is on a formulary. Ask your plan directly and keep its response. Our brand comparison explains why the indication and product name matter.
Sources: NIDDK: Prescription medicines for overweight and obesity · Mochi Health: Public care and pricing FAQs · Lilly: Zepbound prescribing information · Lilly: Mounjaro prescribing information
Affordability should include follow-up
A workable budget leaves room for care over time, including reassessment if side effects or changing health needs interrupt treatment. Ask who will discuss alternatives if the current plan becomes unaffordable.
Cost does not establish that a compounded prescription is appropriate. FDA says compounded GLP-1 drugs should be used only when a patient’s medical needs cannot be met by an approved drug. Read the compounding fieldnote, then use the notebook to bring the financial and clinical questions to one conversation.
The Remedy Meds review adds a useful billing question: is the quote for a calendar month, a 28-day period, or a prepaid term? Write down the dates as well as the dollar amount.
Sources: FDA: Concerns with unapproved GLP-1 drugs · FDA: GLP-1 supply and compounding policy · NIDDK: Prescription medicines for overweight and obesity · Remedy Meds: Initial payment and renewal timing
Put the cancellation stage beside the payment term
Two further providers were checked October 15, 2026. The Amble review examines its displayed GLP-1 plan prices and October 12 terms. A multi-month amount is charged at purchase, and an order sent to the pharmacy becomes nonrefundable under the ordinary rule, including the months it covers. Future renewals have a separate 15-day notice requirement.
The Bliv review separates its promotional headline, plan-dependent medication prices and pay-later presentation. Its terms treat subscriptions, completed clinical evaluations and medication orders differently. The medication cancellation cutoff is prescription transmission to the pharmacy; stopping a platform subscription does not itself cancel a pending prescription.
These policy examples supplement the earlier dated offers above. Confirm the selected product, total charge and actual renewal terms instead of carrying one provider’s rule into another provider’s checkout.
Sources: Amble: compounded GLP-1 offer · Amble: terms updated October 12, 2026 · Bliv: GLP-1 pricing and service page · Bliv: subscriptions, clinical services and refunds
The source shelf
- CoreAge Rx: Tirzepatide product page
Product page read October 5, 2026: $149 starting figure. The separate $129 annual quote was supplied to this publication; an individual checkout was not tested.
- CoreAge Rx: Current promotional offer
External offer link. The supplied $129 monthly equivalent concerns a 12-month tirzepatide quote ($1,548 total), not a claim that this page currently displayed that figure. Confirm selected checkout.
- SuperHealthy Rx: official glp offer
Offer page read October 5, 2026: $135 tirzepatide, $85 semaglutide, optional automatic refill and conditional clinical-ineligibility refund language. Advertised terms, not tested service.
- Likeness Rx — GLP-1 weight care
GLP-1 plan cards and FAQ read October 5, 2026. Term prices, automatic renewal, early first-refill billing and a declined-prescription refund are provider statements; no order was placed.
- Mochi Health: Public care and pricing FAQs
FAQ checked October 5, 2026. $79 one-month membership and compounded tirzepatide from $90, dependent on dose; these are separate fees. Promotional membership offers may differ.
- LillyDirect: Zepbound self-pay options
Manufacturer page checked October 5, 2026: $299 starting self-pay figure for the starting strength, with presentation, supply-period, eligibility and refill-timing conditions. Not an all-strength price.
- Mochi Health: Terms
Platform payment and service terms; read with the selected treatment agreement.
- Mochi Health: Refunds
Cancellation and refund rules can differ for membership and a processed prescription.
- FDA: Managing medicine benefits and risks
General questions for clinical decision-making and medication follow-up.
- NIDDK: Prescription medicines for overweight and obesity
Chronic weight-management decisions and ongoing lifestyle care.
- Lilly: Zepbound prescribing information
Current manufacturer label read October 5, 2026: approved weight-management and moderate-to-severe OSA uses in specified adults; product-specific contraindications and instructions. Does not establish compounded-product equivalence.
- Lilly: Mounjaro prescribing information
Current manufacturer label read October 5, 2026. Diabetes indications and product-specific warnings; not the label for a compounded preparation.
- FDA: Concerns with unapproved GLP-1 drugs
Current FDA page read October 5, 2026. Compounding, dose and ingredient concerns; individual medical need does not establish automatic eligibility or equivalence.
- FDA: GLP-1 supply and compounding policy
Shortage resolution and restrictions on essentially copies; availability requires current professional assessment.
- Remedy Meds: Initial payment and renewal timing
Help article describes payment at sign-up, a 28-day cycle and refill forms. Selected checkout terms may differ.
- Amble: compounded GLP-1 offer
Checked October 15, 2026. Company-published information; service claims and outcomes were not independently tested. The selected order, clinical assessment and pharmacy instructions control individual arrangements.
- Amble: terms updated October 12, 2026
Checked October 15, 2026. Company-published information; service claims and outcomes were not independently tested. The selected order, clinical assessment and pharmacy instructions control individual arrangements.
- Bliv: GLP-1 pricing and service page
Checked October 15, 2026. Company-published information; service claims and outcomes were not independently tested. The selected order, clinical assessment and pharmacy instructions control individual arrangements.
- Bliv: subscriptions, clinical services and refunds
Checked October 15, 2026. Company-published information; service claims and outcomes were not independently tested. The selected order, clinical assessment and pharmacy instructions control individual arrangements.
